Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-22-004923
Filing Date
2022-01-18
Accepted
2022-01-18 16:21:46
Documents
6
Effectiveness Date
2022-01-18

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2136165d1_s8.htm S-8 37153
2 EXHIBIT 4.1 tm2136165d1_ex4-1.htm EX-4.1 299224
3 EXHIBIT 5.1 tm2136165d1_ex5-1.htm EX-5.1 8814
4 EXHIBIT 23.2 tm2136165d1_ex23-2.htm EX-23.2 3158
5 GRAPHIC tm2136165d1_ex23-2img001.jpg GRAPHIC 9029
6 GRAPHIC tm2136165d1_ex23-2img002.jpg GRAPHIC 21067
  Complete submission text file 0001104659-22-004923.txt   391161
Mailing Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5
Business Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 289-910-0850
Cardiol Therapeutics Inc. (Filer) CIK: 0001702123 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-262216 | Film No.: 22535438
SIC: 2836 Biological Products, (No Diagnostic Substances)